# Twitter-enabled Mobile Messaging for Smoking Relapse Prevention (Tweet2Quit)

> **NCT02823028** · PHASE2 · COMPLETED · sponsor: **University of California, Irvine** · enrollment: 980 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** NRT
- **BEHAVIORAL:** Web Guide
- **BEHAVIORAL:** Tweet2Quit

## Key facts

- **NCT ID:** NCT02823028
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2022-09
- **Final completion:** 2022-09
- **Target enrollment:** 980 (ACTUAL)
- **Last updated:** 2024-11-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02823028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02823028, "Twitter-enabled Mobile Messaging for Smoking Relapse Prevention (Tweet2Quit)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02823028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*